Enhabit, Inc./$EHAB
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Enhabit, Inc.
Enhabit Inc provides home health and hospice services in the United States. Its reportable segments are Home Health and Hospice. The Home Health segment includes a comprehensive range of Medicare-certified home nursing services to adult patients in need of care. These services include, among others, skilled nursing, physical, occupational, and speech therapy, medical social work, and home health aide services. The Hospice segment focuses on the quality of life for patients who are experiencing an advanced, life-limiting illness while treating the person and symptoms of the disease, rather than the disease itself. The company generates a majority of its revenue from the Home Health segment.
Ticker
$EHAB
Sector
Primary listing
NYSE
Industry
Health Care Providers & Services
Headquarters
Employees
10,700
ISIN
US29332G1022
Website
Enhabit, Inc. Metrics
BasicAdvanced
$399M
-
-$2.76
1.21
-
Price and volume
Market cap
$399M
Beta
1.21
52-week high
$10.91
52-week low
$6.85
Average daily volume
514K
Financial strength
Current ratio
1.493
Quick ratio
1.416
Long term debt to equity
88.662
Total debt to equity
94.854
Interest coverage (TTM)
1.20%
Profitability
EBITDA (TTM)
79.6
Gross margin (TTM)
48.97%
Net profit margin (TTM)
-13.43%
Operating margin (TTM)
4.80%
Effective tax rate (TTM)
-1.87%
Revenue per employee (TTM)
$100,000
Management effectiveness
Return on assets (TTM)
2.31%
Return on equity (TTM)
-21.36%
Valuation
Price to revenue (TTM)
0.384
Price to book
0.73
Price to tangible book (TTM)
-0.97
Price to free cash flow (TTM)
8.007
Free cash flow yield (TTM)
12.49%
Free cash flow per share (TTM)
98.41%
Growth
Revenue change (TTM)
-1.08%
Earnings per share change (TTM)
66.20%
3-year revenue growth (CAGR)
-2.40%
3-year earnings per share growth (CAGR)
15.51%
What the Analysts think about Enhabit, Inc.
Majority rating from 8 analysts.
Bulls say / Bears say
Enhabit Inc's hospice segment demonstrated robust growth in Q4 2024, with net service revenue increasing by 13.1% and Adjusted EBITDA rising by 13.7% year-over-year, indicating strong operational performance and potential for continued expansion. (ehab.com)
The company successfully reduced its bank debt by $40 million in 2024, including a $10 million reduction in Q4, reflecting a commitment to strengthening its balance sheet and enhancing financial stability. (ehab.com)
Enhabit's strategic focus on payer innovation has led to 48% of home health non-Medicare visits being under improved-rate contracts, diversifying revenue streams and potentially increasing profitability. (ehab.com)
In Q4 2024, Enhabit reported a net loss of $46.0 million, translating to a loss per share of $0.92, significantly below analyst expectations and indicating financial challenges. (gurufocus.com)
The home health segment experienced a 4.3% decline in net service revenue in Q4 2024, primarily due to a 10.4% decrease in Medicare revenue, suggesting potential difficulties in maintaining Medicare patient volumes. (gurufocus.com)
Enhabit recorded a $107.9 million impairment of goodwill in Q3 2024, contributing to a net loss of $110.2 million for the quarter, raising concerns about asset valuation and financial health. (gurufocus.com)
Data summarised monthly by Lightyear AI. Last updated on 6 Jun 2025.
Enhabit, Inc. News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Enhabit, Inc. stock?
Enhabit, Inc. (EHAB) has a market cap of $399M as of July 03, 2025.
What is the P/E ratio for Enhabit, Inc. stock?
The price to earnings (P/E) ratio for Enhabit, Inc. (EHAB) stock is 0 as of July 03, 2025.
Does Enhabit, Inc. stock pay dividends?
No, Enhabit, Inc. (EHAB) stock does not pay dividends to its shareholders as of July 03, 2025.
When is the next Enhabit, Inc. dividend payment date?
Enhabit, Inc. (EHAB) stock does not pay dividends to its shareholders.
What is the beta indicator for Enhabit, Inc.?
Enhabit, Inc. (EHAB) has a beta rating of 1.21. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.